Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment

• Main Authors: Yu Wang (Author), Qianmei Wang (Author), Wei Feng (Author), Qian Yuan (Author), Xiaowei Qi (Author), Sheng Chen (Author), Pu Yao (Author), Qing Dai (Author), Peiyuan Xia (Author), Dinglin Zhang (Author), Fengjun Sun (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Luteolin (Lut) is a natural flavonoid polyphenolic compound with multiple pharmacological activities, such as anti-oxidant, anti-inflammatory, and anti-tumor effects. However, the poor aqueous solubility and low bioactivity of Lut restrict its clinical translation. Herein, we developed a reactive ox...